Jason Kenneth Frankel, MD
Urology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Looking this up.
Hospitals listed: Memorial Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Frankel’s office at (408) 972-3000 to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 036154324Licensed Physician And Surgeon · since 2020 · expires 2023-07-31Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Memorial HospitalBelleville, ILAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of BJC Healthcare, which runs 16 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.131, Oct 2024 – Sep 2025
See every measure and the patient survey for Memorial Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.131 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.84 (0 to 1.81) · 1,061 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.73 (0.43 to 1.04) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.46 (115.62 to 217.3) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 225 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.9 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 578 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 778 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 319 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,248 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 7,887 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.43) · 7,994 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.48 (0.4 to 4.56) · 1,265 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 457 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.01 (0.5 to 3.52) · 1,170 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.15 (1.38 to 14.93) · 466 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.84 (0.12 to 7.56) · 429 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.2 (0.75 to 3.65) · 245 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 6,858 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 206 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.657 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.498 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.509 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.23 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.7 · 1,100 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 16.6 · 137 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.2 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1.4 · 804 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 1,325 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.9 (4.3 to 8.1) · 311 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.6 (8.3 to 13.5) · 311 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.8 · 199 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 13.8 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 502 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 17.3) · 785 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 629 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,322 patients answered, 30% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Medicaid work
$828 in 2022
Medicaid paid $828 for 12 billed services this clinician did in 2022, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 12 | $828 |
| 2022 | 12 | 1 | 12 | $828 |
Drugs they prescribed that Part D paid
$12,398
Pharmacies billed $12,398 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (53 of 320) in 2024. A higher opioid share than 9 in 10 peers; the typical urology clinician is at 2%.
304 generic and fewer than 11 brand-name prescriptions · $12,398 in drug cost · 90 antibiotic prescriptions to 65 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 15 | $6,688 | $446 |
| Tamsulosin | 52 | $763 | $15 |
| Finasteride | 31 | $472 | $15 |
| Hydrocodone-Acetaminophen | 44 | $344 | $8 |
| Ciprofloxacin | 43 | $287 | $7 |
See all 7 drugs
| Myrbetriq | 15 | $6,688 | $446 |
| Tamsulosin | 52 | $763 | $15 |
| Finasteride | 31 | $472 | $15 |
| Hydrocodone-Acetaminophen | 44 | $344 | $8 |
| Ciprofloxacin | 43 | $287 | $7 |
| Tadalafil | 15 | $232 | $15 |
| Cephalexin | 28 | $185 | $7 |
Year by year
| 2024 | 320 | 141 | 17% (53) | None | $12,398 |
| 2023 | 365 | 104 | None | 15% | $39,540 |
| 2022 | 427 | 112 | None | 17% | $45,819 |
| 2021 | 295 | 98 | 6% (17) | 5% | $14,219 |
| 2020 | 93 | 45 | None | None | $4,558 |
| 2019 | 41 | 26 | None | None | $1,167 |
| 2018 | 57 | 29 | 23% (13) | None | $316 |
| 2017 | 58 | 36 | 22% (13) | None | $1,340 |
| 2016 | 138 | 89 | 49% (67) | None | $2,136 |
| 2015 | 132 | 84 | 43% (57) | None | $1,794 |
| 2014 | 100 | 61 | 38% (38) | None | $2,212 |
| 2013 | 15 | None | None | 0% | $137 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Myrbetriq | 52 | $31,345 | $603 |
| Tamsulosin | 110 | $2,130 | $19 |
| Estradiol | 18 | $1,563 | $87 |
| Finasteride | 63 | $1,254 | $20 |
| Oxybutynin Chloride Er | 48 | $960 | $20 |
| Ciprofloxacin | 13 | $101 | $8 |
2022: 7 drugs
| Myrbetriq | 65 | $36,706 | $565 |
| Oxybutynin Chloride Er | 58 | $2,412 | $42 |
| Finasteride | 78 | $1,535 | $20 |
| Tamsulosin | 124 | $1,444 | $12 |
| Methenamine Hippurate | 11 | $780 | $71 |
| Nitrofurantoin Mono-Macro | 13 | $401 | $31 |
| Ciprofloxacin | 23 | $184 | $8 |
2021: 6 drugs
| Myrbetriq | 14 | $7,808 | $558 |
| Finasteride | 63 | $1,141 | $18 |
| Tamsulosin | 90 | $1,118 | $12 |
| Oxybutynin Chloride Er | 28 | $580 | $21 |
| Hydrocodone-Acetaminophen | 12 | $56 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $48 | $4 |
2020: 2 drugs
| Tamsulosin | 52 | $712 | $14 |
| Finasteride | 11 | $110 | $10 |
2019: 1 drug
| Tamsulosin | 23 | $368 | $16 |
2018: 1 drug
| Finasteride | 14 | $117 | $8 |
2016: 4 drugs
| Oxycodone-Acetaminophen | 27 | $238 | $9 |
| Hydrocodone-Acetaminophen | 23 | $222 | $10 |
| Ciprofloxacin | 36 | $171 | $5 |
| Oxycodone | 13 | $142 | $11 |
2015: 4 drugs
| Hydrocodone-Acetaminophen | 26 | $217 | $8 |
| Oxycodone-Acetaminophen | 19 | $199 | $10 |
| Ciprofloxacin | 26 | $97 | $4 |
| Cephalexin | 12 | $47 | $4 |
2014: 2 drugs
| Oxycodone-Acetaminophen | 19 | $242 | $13 |
| Ciprofloxacin | 22 | $95 | $4 |
Money from drug and device companies
$369 in 2025
| 2025 | 2 | 3 | None | $369 |
| 2023 | 2 | 2 | None | $42 |
| 2022 | 2 | 2 | None | $79 |
| 2019 | 4 | 4 | None | $273 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| C. R. Bard Inc. & Subsidiaries | Bard Urinary Drainage Bag | $327 | 2 payments
|
| Ferring Pharmaceuticals | Adstiladrin | $42 | 1 payment
|
See all 3 published payments
| Ferring Pharmaceuticals | Meals · 2025-11-03 | Adstiladrin | $42 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-04-26 | Bard Urinary Drainage Bag | $198 |
| C. R. Bard Inc. & Subsidiaries | Meals · 2025-04-25 | Bard Urinary Drainage Bag | $128 |
See earlier years (2023, 2022, 2019)
2023: $42
| Myriad Genetic Laboratories | Prolaris | $23 | 1 payment
|
| Baxter Healthcare | Tisseel | $19 | 1 payment
|
2022: $79
| Astellas Pharma US | None | $65 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $14 | 1 payment
|
2019: $273
| Ferring Pharmaceuticals | Firmagon | $123 | 1 payment
|
| Dendreon Pharmaceuticals | Provenge | $58 | 1 payment
|
| Astellas Pharma US | None | $48 | 1 payment
|
| Merck Sharp & Dohme | Keytruda | $44 | 1 payment
|
Professional record
- NPI
- 1750729976
- Licence
- IL 036154324Illinois 036154324: Not Renewed
- Trained
- Albany Medical College of Union University, 2013
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MO 200088624
- Taxonomy
- Urology (208800000X)
- Mailing address
- 1425 S Main St, Walnut Creek, CA, 94596
- NPI first listed
- 2013-06-10
- NPI last updated
- 2023-09-25
- NPI record certified
- 2023-09-25
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.